LACTB
LACTB (lactamase beta, also known as MRPL56 and FLJ14902) is a mitochondrial serine protease that regulates mitochondrial lipid metabolism. It belongs to the peptidase S12 family and has been described as a tumour suppressor in breast cancer cells. Browse Assay Genie's current range of LACTB research reagents below, or read on for the biology behind the target.
LACTB is a mitochondrial serine protease that acts as a regulator of mitochondrial lipid metabolism. It decreases protein levels of PISD, the mitochondrial enzyme that converts phosphatidylserine (PtdSer) to phosphatidylethanolamine (PtdEtn), and so affects the lipid composition handled within the organelle. It is not yet clear whether LACTB acts directly, by proteolysis of PISD, or through proteolysis of another lipid metabolism protein.
The LACTB gene encodes a mitochondrially localised protein with sequence similarity to prokaryotic beta-lactamases, and the protein is placed in the serine beta lactamase family and the peptidase S12 family. Many of the residues responsible for beta-lactamase activity are not conserved, which suggests that LACTB has a different enzymatic function from the bacterial enzymes. Alternative splicing produces multiple transcript variants that encode different protein isoforms. The mouse ortholog is Lactb.
LACTB is annotated as a tumour suppressor able to inhibit the proliferation of multiple types of breast cancer cells, probably by promoting lower PISD levels and thereby altering mitochondrial lipid metabolism. Increased expression of the related mouse gene has been associated with obesity. The protein was previously named mitochondrial ribosomal protein L56 (MRPL56), a name that now survives as an alias. The related protein LACTB2 is a separate gene product and is covered on its own page.
LACTB lowers PISD levels, which affects the conversion of phosphatidylserine to phosphatidylethanolamine inside mitochondria.
LACTB can inhibit proliferation of multiple types of breast cancer cells, making it a tumour suppressor of interest.
Increased expression of the related mouse gene has been associated with obesity, linking LACTB to metabolic research.
LACTB resembles prokaryotic beta-lactamases but lacks many of the residues for that activity, which points to a different enzymatic role.
LACTB is a mitochondrial serine protease that regulates mitochondrial lipid metabolism. It decreases levels of PISD, the enzyme that converts phosphatidylserine to phosphatidylethanolamine. Whether it cleaves PISD directly or another lipid metabolism protein is still unclear. It also acts as a tumour suppressor in breast cancer cells.
The HGNC name is lactamase beta, and UniProt lists serine beta-lactamase-like protein LACTB, mitochondrial. Aliases include MRPL56 and FLJ14902. MRPL56 comes from the earlier name mitochondrial ribosomal protein L56. Alternative splicing gives several transcript variants and protein isoforms.
LACTB resembles prokaryotic beta-lactamases, but many residues needed for beta-lactamase activity are not conserved, so its enzymatic function probably differs. It belongs to the peptidase S12 family. A mouse ortholog, Lactb, exists; check the datasheet of any product for its validated reactivity.
A related lactamase-family protein with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P83111; product specifications from Assay Genie datasheets.